Peer Review reports
From: Clinical and economic impact of molecular testing for BRAF fusion in pediatric low-grade Glioma
| Original Submission | ||
|---|---|---|
| 6 Aug 2021 | Submitted | Original manuscript |
| 28 Aug 2021 | Reviewed | Reviewer Report |
| 4 Sep 2021 | Reviewed | Reviewer Report - Rahul Krishnatry |
| 8 Nov 2021 | Author responded | Author comments - Petros Pechlivanoglou |
| Resubmission - Version 2 | ||
| 8 Nov 2021 | Submitted | Manuscript version 2 |
| 15 Nov 2021 | Author responded | Author comments - Petros Pechlivanoglou |
| Resubmission - Version 3 | ||
| 15 Nov 2021 | Submitted | Manuscript version 3 |
| 23 Nov 2021 | Reviewed | Reviewer Report - Rahul Krishnatry |
| 2 Dec 2021 | Reviewed | Reviewer Report |
| 3 Dec 2021 | Author responded | Author comments - Petros Pechlivanoglou |
| Resubmission - Version 4 | ||
| 3 Dec 2021 | Submitted | Manuscript version 4 |
| Publishing | ||
| 7 Dec 2021 | Editorially accepted | |
| 3 Jan 2022 | Article published | 10.1186/s12887-021-03069-1 |
You can find further information about peer review here.